Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
RESEARCH TOOLSreports
Holding GB:NIOX?
Track your performance easily
NIOX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range57.20p - 80.00p
Previous Close63.8p
Volume456.81K
Average Volume (3M)1.05M
Market Cap
£250.37M
Enterprise Value231.57M
Total Cash (Recent Filing)£19.90M
Total Debt (Recent Filing)£1.10M
Price to Earnings (P/E)22.7
Beta0.82
Next Earnings
Mar 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2024Dividend Yield1.59%
Share Statistics
EPS (TTM)0.03
Shares Outstanding424,127,241
10 Day Avg. Volume1,061,033
30 Day Avg. Volume1,047,793
Standard Deviation0.16
R-Squared0.11
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)326.32
Price to Sales (P/S)6.94
Price to Cash Flow (P/CF)22.90
P/FCF Ratio23.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.00pPrice Target Upside20.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Circassia Pharmaceuticals News
PremiumCompany Announcements
Niox Group Director’s Associate Buys Additional Shares
PremiumCompany Announcements
NIOX Group’s Shareholders Adjust Holdings Amid Tender Offer
PremiumCompany Announcements
NIOX Group Completes £21M Share Buyback SuccessfullyPremiumCompany Announcements
NIOX Group’s Tender Offer Gains Strong Shareholder SupportPremiumCompany Announcements
Circassia Pharmaceuticals Reports Share Capital Update
PremiumCompany Announcements
Circassia Pharmaceuticals Announces Strong H1 2024 Results
PremiumCompany Announcements
Circassia Pharmaceuticals Announces Share BuybackPremiumCompany Announcements
Circassia Pharmaceuticals Reports Shareholding ShiftOptions Prices
Currently, No data available
---
Ownership Overview
0.79% Insiders
<0.01% Other Institutional Investors
99.01% Public Companies and
Individual Investors
NIOX FAQ
What was Circassia Pharmaceuticals PLC’s price range in the past 12 months?
Circassia Pharmaceuticals PLC lowest share price was 57.20p and its highest was 80.00p in the past 12 months.
What is Circassia Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Circassia Pharmaceuticals PLC’s upcoming earnings report date?
Circassia Pharmaceuticals PLC’s upcoming earnings report date is Mar 25, 2025 which is in 135 days.
How were Circassia Pharmaceuticals PLC’s earnings last quarter?
Circassia Pharmaceuticals PLC released its earnings results on Sep 24, 2024. The company reported 0.01p earnings per share for the quarter, beating the consensus estimate of N/A by 0.01p.
Is Circassia Pharmaceuticals PLC overvalued?
According to Wall Street analysts Circassia Pharmaceuticals PLC’s price is currently Undervalued.
Does Circassia Pharmaceuticals PLC pay dividends?
Circassia Pharmaceuticals PLC pays a Notavailable dividend of 1p which represents an annual dividend yield of 1.59%. See more information on Circassia Pharmaceuticals PLC dividends here
What is Circassia Pharmaceuticals PLC’s EPS estimate?
Circassia Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Circassia Pharmaceuticals PLC have?
Circassia Pharmaceuticals PLC has 397,980,560 shares outstanding.
What happened to Circassia Pharmaceuticals PLC’s price movement after its last earnings report?
Circassia Pharmaceuticals PLC reported an EPS of 0.01p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.242%.
Which hedge fund is a major shareholder of Circassia Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in GB:NIOX
---
Circassia Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
77.00p (20.69% Upside)
77.00p (20.69% Upside)
Insider Transactions
Sold Shares
Worth £162.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.44%
12-Months-Change
Fundamentals
Return on Equity
13.52%
Trailing 12-Months
Asset Growth
-8.66%
Trailing 12-Months
Company Description
Circassia Pharmaceuticals PLC
Circassia Group PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of revenue from the US and also has a presence in EU, Asia Pacific and Rest of world.
---
NIOX Stock 12 Month Forecast
Average Price Target
77.00p
▲(20.69% Upside)
Technical Analysis
Best Analysts Covering NIOX
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-8.00%
reiterated a buy rating 2 months ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -8.00% per trade.
---